Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials

Published:2021-11-25 Issue: Volume: Page:1-9
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Kow Chia Siang¹^ORCID,Javed Amaan²,Ramachandram Dinesh¹^ORCID,Hasan Syed Shahzad³⁴^ORCID

Affiliation:

1. School of Pharmacy, Monash University Malaysia, Petaling Jaya, Malaysia

2. University College of Medical Sciences, University of Delhi, Delhi, India

3. School of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK

4. School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia

Funder

funded

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2022.2000861

Reference31 articles.

1. An interactive web-based dashboard to track COVID-19 in real time

2. Genomic evidence for reinfection with SARS-CoV-2: a case study

3. Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic

4. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model

5. In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons learnt from broad-spectrum coronavirus antiviral drug discovery;Expert Opinion on Drug Discovery;2024-07-30

2. Small-molecule antiviral treatments for COVID-19: A systematic review and network meta-analysis;International Journal of Antimicrobial Agents;2024-03

3. Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog;BioTech;2023-10-30

4. Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics;Molecular Aspects of Medicine;2023-06

5. Therapie von COVID-19 unter Berücksichtigung von Lebererkrankungen;Die Gastroenterologie;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3